Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Korea.
Department of Psychiatry, Yonsei University Wonju College of Medicine, Wonju, Korea.
Sci Rep. 2018 Apr 20;8(1):6334. doi: 10.1038/s41598-018-24653-z.
Psychological stress (PS) increases endogenous glucocorticoids (GC) by activating the hypothalamic-pituitary-adrenal axis. The negative effects of GC on skin barrier function under PS have been well-established. However, endogenous GC can also be active when cortisone (inactive form) is converted to cortisol (active form) by 11β-hydroxysteroid dehydrogenase type I (11ß-HSD1) in the peripheral tissue. Here, we evaluated the changes in 11ß-HSD1 and barrier function under PS. Elevated 11ß-HSD1 in oral mucosa correlated with increased cortisol in the stratum corneum and deteriorated barrier function. Expression of 11ß-HSD1 in the oral mucosa correlated with that in the epidermal keratinocytes. We further investigated whether barrier function improved when PS was relieved using a selective serotonin reuptake inhibitor (SSRI) in patients with anxiety. Decreased 11ß-HSD1 and improved barrier function were observed after SSRI treatment. The collective findings suggest that elevated 11ß-HSD1 under PS increases the level of cutaneous GC and eventually impairs barrier function. PS-alleviating drugs, such as SSRI, may help to treat PS-aggravated skin diseases.
心理应激(PS)通过激活下丘脑-垂体-肾上腺轴增加内源性糖皮质激素(GC)。GC 对 PS 下皮肤屏障功能的负面影响已得到充分证实。然而,内源性 GC 也可以在皮质酮(无活性形式)被外周组织中的 11β-羟类固醇脱氢酶 1 型(11ß-HSD1)转化为皮质醇(活性形式)时发挥作用。在这里,我们评估了 PS 下 11ß-HSD1 和屏障功能的变化。口腔黏膜中 11ß-HSD1 的升高与角质层中皮质醇的增加和屏障功能的恶化相关。口腔黏膜中 11ß-HSD1 的表达与表皮角质形成细胞中的表达相关。我们进一步研究了在焦虑症患者中使用选择性 5-羟色胺再摄取抑制剂(SSRI)缓解 PS 时屏障功能是否会改善。在 SSRI 治疗后观察到 11ß-HSD1 减少和屏障功能改善。这些研究结果表明,PS 下升高的 11ß-HSD1 增加了皮肤 GC 的水平,最终损害了屏障功能。PS 缓解药物,如 SSRI,可能有助于治疗 PS 加重的皮肤病。